Evidence map›Paper›PMID 30793524›Full record

ArticleCancer medicine2019

Body mass index, body shape, and risk of nasopharyngeal carcinoma: A population-based case-control study in Southern China.

Ruimei Feng, Ellen T Chang, Zhiwei Liu, Qing Liu, Yonglin Cai, Zhe Zhang, Guomin Chen, Qi-Hong Huang, Shang-Hang Xie, Su-Mei Cao and 13 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. A novel causal model for nasopharyngeal carcinoma.Cancer causes & control : CCC · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 3 countries.

Ruimei FengDepartment of Cancer Prevention Center, Sun Yat-sen University Cancer Center, Guangzhou, China.
Ellen T ChangHealth Sciences Practice, Exponent, Inc., Menlo Park, California.
Zhiwei LiuDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Qing LiuDepartment of Cancer Prevention Center, Sun Yat-sen University Cancer Center, Guangzhou, China.
Yonglin CaiDepartment of Clinical Laboratory, Wuzhou Red Cross Hospital, Wuzhou, China.
Zhe ZhangDepartment of Otolaryngology-Head & Neck Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Guomin ChenState Key Laboratory for Infectious Diseases Prevention and Control, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Qi-Hong HuangSihui Cancer Institute, Sihui, China.
Shang-Hang XieDepartment of Cancer Prevention Center, Sun Yat-sen University Cancer Center, Guangzhou, China.
Su-Mei CaoDepartment of Cancer Prevention Center, Sun Yat-sen University Cancer Center, Guangzhou, China.ORCID 0000-0003-1749-517X
Yu ZhangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.
Jingping YunState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.
Wei-Hua JiaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.
Yuming ZhengDepartment of Clinical Laboratory, Wuzhou Red Cross Hospital, Wuzhou, China.
Jian LiaoCangwu Institute for Nasopharyngeal Carcinoma Control and Prevention, Wuzhou, China.
Yufeng ChenDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Longde LinMinistry of Education, Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Nanning, China.
Ingemar ErnbergDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Guangwu HuangDepartment of Otolaryngology-Head & Neck Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yi ZengState Key Laboratory for Infectious Diseases Prevention and Control, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Yi-Xin ZengState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.
Hans-Olov AdamiDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Weimin YeDepartment of Cancer Prevention Center, Sun Yat-sen University Cancer Center, Guangzhou, China.ORCID 0000-0002-6859-4648
Sun Yat-sen University · CNKarolinska Institutet · SEGuangxi Medical University · CNWuzhou University · CNCancer Prevention Institute of California · USHarvard University · USTumor Hospital of Guangxi Medical University · CN

Funding

Gene-environment EBV Interactions in the Etiology of Nasopharyngeal Carcinoma (NPR01CA115873 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI ADAMI, HANS-OLOV · 2008 to 2013
$2.4M
NCI NIH HHS R01 CA115873
6 · The paper itself

Abstract

Whether the association between body size or shape and nasopharyngeal carcinoma (NPC) risk exists or varies by age-specific body size indicators is unclear. In a population-based case-control study conducted in Southern China between 2010 and 2014, self-reported height, weight, and body shape at age 20 and 10 years before interview were collected from 2448 histopathologically confirmed NPC cases and 2534 population-based controls. Body mass index (BMI) was categorized according to the World Health Organization guidelines for Asian populations: underweight (<18.5 kg/m

Indexed as

Body Mass IndexBody SizeAdultAgedAgingAnthropometryCase-Control StudiesChinaFemaleHumansLife StyleMaleMiddle AgedNasopharyngeal CarcinomaNasopharyngeal NeoplasmsOverweightbody mass indexbody shapecase-control studynasopharyngeal carcinomaSouthern China

Identifiers

PMID30793524
PMCPMC6488148
OpenAlexW2917864257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.